Mednet Logo
HomeMedical OncologyQuestion

What adjuvant treatment would you offer a patient with adenocarcinoma of the mid-esophagus cT2N0M0 who underwent upfront esophagectomy, which showed T2N1 disease with negative margins?

2 Answers
Mednet Member
Mednet Member
Medical Oncology · Memorial Sloan Kettering Cancer Center

Unfortunately, it's not an uncommon situation for patients to be upstaged following surgery without prior preoperative chemotherapy. This is because imaging modalities and even endoscopic ultrasound have limited sensitivity for detecting lymph node metastases.

A related issue is whether patients with...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Medical Oncology · Mary Lanning Healthcare Morrison Cancer Center/University of Nebraska Medical Center Adjunct Faculty

Mid and distal esophageal adenocarcinomas are biologically and clinically similar, with comparable metastatic patterns and outcomes and show similar molecular profiling. (Nakauchi et al., PMID 38841851)

For resectable esophageal adenocarcinomas, the NCCN guidelines list FLOT + durvalumab as a periope...

Register or Sign In to see full answer

What adjuvant treatment would you offer a patient with adenocarcinoma of the mid-esophagus cT2N0M0 who underwent upfront esophagectomy, which showed T2N1 disease with negative margins? | Mednet